DURECT Corp (NASDAQ:DRRX)
| 2.04 Delayed Data As of 4:00pm ET |  -0.01 / -0.49%Today’s Change | 0.95 Today|||52-Week Range 2.96 | -1.69% Year-to-Date |
Latest DRRX News | Press Releases
| Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates Mar 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.05 |
| Today’s open | 2.31 |
| Day’s range | 1.99 - 2.09 |
| Volume | 79,501 |
| Average volume (3 months) | 1,735,973 |
| Market cap | $448.4M |
Data as of 4:00pm ET, 03/08/2021
Growth & Valuation
| Earnings growth (last year) | +97.49% |
| Earnings growth (this year) | -166.67% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +1.85% |
| P/E ratio | NM |
| Price/Sales | 13.71 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRNAVerona Pharma PLC | +0.04 | +0.46% |
| AVDLAvadel Pharmaceutica... | -0.24 | -3.10% |
| SPROSpero Therapeutics I... | -0.08 | -0.49% |
| --China Health Group I... | -0.02 | -4.30% |
Data as of 4:00pm ET, 03/08/2021
Financials
| Next reporting date | May 6, 2021 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $30.1M |
| Annual profit (last year) | -$582.0K |
| Net profit margin | -47.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cupertino, California |
Forecasts
